Skip to Content
Corporate Sponsorships
Member Login
Search
Member Login
Give
Corporate Sponsorship
SEARCH
About Us
About ASTCT
Board of Directors
President Message
Partner Organizations
For Media
Contact ASTCT
Committees
Membership
Become a Member
Member Spotlights
Member Directory
Special Interest Groups
Community Forum
Mentor Match
Education
Practice Guidelines
Learning Center
Patient Education
Coverage, Coding, Billing
CAR-T Therapy Coding and Billing Guide
HCT Coding and Billing Resources
Payer RFI Forms
Meetings
Meetings
Meetings Calendar
Translational Science Training Course
Gene Therapy Summit
Publications & Podcasts
Journal: Transplantation and Cellular Therapy
Trending Research: Nucleus
Podcast: ASTCT Talks
Newsletters
Tandem Meetings News
Careers
Job Connections
Fellowship Programs
Fellowship Connections
Grants
International Trainee Observership
Awards
Advocacy
ASTCT Advocacy
Policy Updates
Policy Letters and Statements
ACCESS Initiative
Hill Day
Trending topics and news in HCT and Cellular Therapy
Topics to Explore
ASTCT NEWS
BISPECIFICS
CAR T
GVHD
MRD
SCIENCE HIGHLIGHTS
In-Person
Published on March 05, 2024
Clinical Research Training Course
More links
...Clinical Research Training Course
-
RELATED NEWS
GVHD
Post-HCT outcomes for older MSDs and younger MUDs
by Blood Advances
Study data suggest donor age and HLA status influence outcomes in older patients receiving post-transplant cyclophosphamide as graft-versus-host disease prophylaxis following hematopoietic cell...
GVHD
High Melphalan Exposure Increases the Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation
by Alex Kadhim
In a recent study, researchers from the University of California, San Francisco, have demonstrated that high exposure to melphalan significantly increases the risk of graft-versus-host disease...